← FDA Drug Approvals (Drugs@FDA)

CIPROFLOXACIN AND DEXAMETHASONE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: UPSHER SMITH LABS · Approved 2026-01-06

Drug application

FDA Application #

ANDA216487

Application type

Abbreviated New Drug Application (Generic)

Brand name

CIPROFLOXACIN AND DEXAMETHASONE

Generic name

CIPROFLOXACIN HYDROCHLORIDE AND DEXAMETHASONE

Active ingredients

CIPROFLOXACIN; DEXAMETHASONE

Dosage form

SUSPENSION/DROPS

Route

OTIC

Marketing status

Prescription

Sponsor

UPSHER SMITH LABS

Manufacturer

Upsher-Smith Laboratories, LLC

First approval

2026-01-06

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown